Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities

Z Huang, Z Zhang, C Zhou, L Liu, C Huang - MedComm, 2022 - Wiley Online Library
Epithelial–mesenchymal transition (EMT) is a program wherein epithelial cells lose their
junctions and polarity while acquiring mesenchymal properties and invasive ability …

EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness

E Sánchez-Tilló, Y Liu, O de Barrios, L Siles… - Cellular and molecular …, 2012 - Springer
Cancer is a complex multistep process involving genetic and epigenetic changes that
eventually result in the activation of oncogenic pathways and/or inactivation of tumor …

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

L Ma, J Young, H Prabhala, E Pan, P Mestdagh… - Nature cell …, 2010 - nature.com
MicroRNAs (miRNAs) are increasingly implicated in regulating the malignant progression of
cancer. Here we show that miR-9, which is upregulated in breast cancer cells, directly …

The regulatory role of microRNAs in EMT and cancer

A Zaravinos - Journal of oncology, 2015 - Wiley Online Library
The epithelial to mesenchymal transition (EMT) is a powerful process in tumor invasion,
metastasis, and tumorigenesis and describes the molecular reprogramming and phenotypic …

Molecular networks that regulate cancer metastasis

D Spano, C Heck, P De Antonellis, G Christofori… - Seminars in cancer …, 2012 - Elsevier
Tumor metastases are responsible for approximately 90% of all cancer-related deaths.
Although many patients can be cured, in the US and UK, cancer still causes 730,000 deaths …

Raf kinases in cancer–roles and therapeutic opportunities

G Maurer, B Tarkowski, M Baccarini - Oncogene, 2011 - nature.com
Raf are conserved, ubiquitous serine/protein kinases discovered as the cellular elements
hijacked by transforming retroviruses. The three mammalian RAF proteins (A, B and CRAF) …

Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression

M Aleku, P Schulz, O Keil, A Santel, U Schaeper… - Cancer …, 2008 - aacrjournals.org
We have previously described a small interfering RNA (siRNA) delivery system (AtuPLEX)
for RNA interference (RNAi) in the vasculature of mice. Here we report preclinical data for …

Epithelial–mesenchymal transition and the invasive potential of tumors

N Gavert, A Ben-Ze'ev - Trends in molecular medicine, 2008 - cell.com
The development of metastasis requires the movement and invasion of cancer cells from the
primary tumor into the surrounding tissue. To acquire such invasive abilities, epithelial …

Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer

RM Ostroff, WL Bigbee, W Franklin, L Gold, M Mehan… - PloS one, 2010 - journals.plos.org
Background Lung cancer is the leading cause of cancer deaths worldwide. New diagnostics
are needed to detect early stage lung cancer because it may be cured with surgery …

Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in …

F Ogura, S Wakao, Y Kuroda… - Stem cells and …, 2014 - liebertpub.com
In this study, we demonstrate that a small population of pluripotent stem cells, termed
adipose multilineage-differentiating stress-enduring (adipose-Muse) cells, exist in adult …